The federal government has announced a new competition taskforce supported by a former ACCC chair that will look into reforms of the country’s merger laws, market concentration and non-compete employee clauses.
Dominique Grubisa has come up short in her bid to have the Australian Competition and Consumer Commission file formal pleadings in its case alleging she misled students enrolled in her real estate investing and wealth management courses.
Qantas faces a class action on behalf of hundreds of thousands of customers who allegedly never received refunds after flights were cancelled during the COVID-19 pandemic.
Mercer Superannuation is likely to admit liability in the corporate regulator’s maiden greenwashing case, a court has heard.
After being hit by a $200 million claim in Australia, infant formula company Care A2 Plus is asking the court to block US business partner Gensco from filing a second lawsuit in its home country, which it says is intended to “harass and split the resources” of CAP and its directors.
Two class actions against Victorian aged care providers on behalf of families of residents who died due to alleged failures during the COVID-19 pandemic have appealed a ruling that rejected their bid for insurance and financial information to assist in mediation.
A class action against Carnival over norovirus outbreaks on its Sun Princess cruise ship has defeated the cruise operator’s second strike out bid, with a judge saying the failure to identify what exactly went wrong “may not be fatal” to the case.
Noumi has admitted in a case by ASIC to breaching its continuous disclosure obligations by overstating the value of its inventory and failing to give a true and fair view of the company’s financial position.
Australian infant formula company Care A2 Plus has hit back at a $200 million lawsuit by US business partner Gensco, arguing the distributor did not properly execute the agreement at the heart of the dispute as allegations of phantom companies fly.
IG Markets has been hit with a second class action for offering “highly risky and unsuitable financial products” to retail investors, with a third competing proceeding in the works.